Dr Laeticia Lichtenstein
- Position: Postdoctoral research assistant
- Areas of expertise: Cardiovascular diseases; Physiology; Obesity; Inflammation; Lipoprotein; Atherosclerosis; Cholesterol; Bile-acids; Liver; Liver disease; NAFLD; Endothelium; Reverse cholesterol transport; Calcium
- Email: L.Lichtenstein@leeds.ac.uk
- Phone: +44(0)113 343 9509
- Location: 7 Light Building
- Website: | Twitter | LinkedIn | Researchgate | ORCID
I graduated in Pharmacology innovation at the University of Toulouse (University Paul Sabatier) in France before my PhD study in The Netherlands with Prof Sander Kersten at Wageningen University and a postdoctoral training at The Institute of metabolic and cardiovascular diseases in Toulouse.
I am currently a post doctoral researcher in the research group of Professor David Beech.
My research focuses on understanding the mechanisms involving shear stress and non-alcoholic fatty liver disease (NAFLD). NAFLD is the fastest-growing liver disease in the Western world with important implications for cardiovascular health.
My research aims to elucidate the role of the calcium- and sodium- permeable Piezo1 channel in 1) NAFLD development and 2) atherosclerosis development.
Most of the methods used in this project ranges from lipidomic (extraction and quantification of lipids) to molecular biology (extraction and quantification of gene and protein expression), pharmacology (drug treatment / development) biophysics (light sheet, confocal and electron microscopy) anatomical pathology ( histopathology and immunohistochemistry on paraffin and cryo-sections of tissues) and in-vivo studies.
- PhD in Nutrition (University of Wageningen, The Netherlands)
- Msc in Pharmacology (University of Toulouse III, France)
- Bsc in cellular biology (University of Toulouse III, France)
- EASL the home of Hepatology
- NSFA nouvelle société Française d'athérosclerose
I lecture CARD3190 Cardiovascular Molecular Pharmacology Module in key concepts in molecular pharmacology (part of the IBsc of cardiovascular Medicine).
Research groups and institutes
- Leeds Institute of Cardiovascular and Metabolic Medicine